In our previous work, we identified a pan-histone deacetylase (HDAC) inhibitor, givinostat (ITF2357), which effectively downregulates CRLF2r BCP-ALL [27]. The gene discussed is OPN1SW; the disease is acute lymphoblastic leukemia.